-
May 8, 2008
Firefighters show higher risks of certain cancers
NEW YORK (Reuters Health) - A new study suggests that firefighters face higher-than-average risks of several types of cancer, adding to evidence that the job carries hazards beyond the fires themselves.
-
April 22, 2008
Large waist may raise death risk for women
NEW YORK (Reuters Health) - Women with large bellies may die earlier of heart disease and cancer than other women, regardless of their weight, a large U.S. study suggests.
-
April 21, 2008
Kidney cancer may be linked to multiple myeloma
NEW YORK (Reuters Health) - For the first time, researchers have evidence of an association between renal cell carcinoma and multiple myeloma, a type of blood cancer, one that "cannot be explained by random incidence alone," they say.
-
February 15, 2008
British researchers link obesity to more cancers
LONDON (Reuters) - Obesity can double the risk of several cancers, according to a study published on Friday that for the first time also links being overweight with a number of less common forms of the disease.
-
February 13, 2008
Partial kidney removal under-used for small tumors
NEW YORK (Reuters Health) - Patients with small kidney tumors are more likely to have "radical nephrectomy" (i.e., complete surgical removal of the affected kidney) than partial nephrectomy, despite evidence showing that the two approaches are equally effective, new research shows.
-
February 13, 2008
Sutent cancer drug causes heart failure in some
WASHINGTON (Reuters) - Fifteen percent of patients who took Sutent, a pill used to treat kidney and stomach cancers, developed heart failure, U.S. researchers reported on Wednesday.
-
January 30, 2008
Nexavar shows promise in acute myeloid leukemia
CHICAGO (Reuters) - The kidney cancer pill Nexava, know generically as sorafenib, has shown promise in treating a small number of people with a type of blood cancer known as acute myeloid leukemia, or AML, U.S. researchers said on Tuesday.
-
January 22, 2008
Nexavar significantly boosts hypertension risk: study
LONDON (Reuters) - Bayer AG and Onyx Pharmaceutical Inc.'s key cancer drug Nexavar significantly raises the risk of high blood pressure, U.S. researchers said on Tuesday.
-
December 24, 2007
Coffee, tea linked to lower risk of kidney cancer
NEW YORK (Reuters Health) - Coffee and tea lovers may have a slightly reduced risk of developing kidney cancer, research hints.
-
December 14, 2007
Pfizer cancer drug Sutent linked with heart risks
CHICAGO (Reuters) - Pfizer Inc's cancer drug Sutent may have toxic effects on the heart, U.S. researchers said Thursday.
-
October 5, 2007
Belly fat, weight cycling ups kidney cancer risk
NEW YORK (Reuters Health) - Postmenopausal women who are overweight or obese appear to have a greater risk of developing, renal cell carcinoma, a common form of kidney cancer, and study findings suggest that a larger waist girth and a history of weight loss and regain further increase this risk.
-
September 7, 2007
Racial differences in kidney cancer care, outcome
NEW YORK (Reuters Health) - There are disparities in the treatment and outcome between older black and white patients who have renal cell cancer, with blacks having significantly lower survival rates, according to a new study.
-
August 27, 2007
UPDATE 2-Bayer's Nexavar extends life in Asia trial
FRANKFURT (Reuters) - A late-stage clinical liver cancer trial with Nexavar in the Asia-Pacific region was halted so patients could get the drug sooner after encouraging results, said Bayer and Onyx Pharmaceuticals.
-
August 24, 2007
Alcohol may lower risk of kidney cancer
NEW YORK (Reuters Health) - Alcohol consumption may lower the risk of developing kidney cancer, according to a report in the British Journal of Cancer.
-
August 16, 2007
Control tobacco, food ads to beat cancer -panel
WASHINGTON (Reuters Life!) - A new presidential report on cancer takes on not only tobacco companies but the food industry while calling on the federal government to "cease being a purveyor of unhealthy foods" and switch to policies that encourage Americans to eat vegetables and exercise.
-
August 9, 2007
Sunbathers warned as skin cancer rates rise rapidly
LONDON (Reuters) - Holidaymakers were warned on Thursday to protect themselves in the sun and avoid getting burnt after figures revealed skin cancer has become the fastest growing form of cancer in Britain.
-
August 2, 2007
Minimally invasive therapy destroys kidney cancer
NEW YORK (Reuters Health) - Patients with kidney cancer who are poor candidates for surgery can be treated using a less invasive alternative, according to a study conducted at Wake Forest University in Winston-Salem, North Carolina.
-
August 1, 2007
Childhood cancer mortality high in UK in children
LONDON (Reuters) - Children with cancer in Britain do not live as long as those with the disease in other European countries, according to British researchers who urged politicians to invest more to address the problem.
-
June 4, 2007
Liver cancer drug extends life 3 months
CHICAGO (Reuters) - A drug already used to treat kidney cancer became the first medicine to extend the life of patients with advanced liver cancer in a clinical trial, adding about 3 months to survival compared to a placebo, according to a study released on Monday.
-
June 4, 2007
Cancer rates elevated after hyperthyroid treatment
NEW YORK (Reuters Health) - Patients who are treated with radioactive iodine for an over active thyroid, a condition also referred to as hyperthyroidism, have an increased risk of cancer -- especially cancers of the stomach, kidney, and breast -- according to the results of a study published in the medical journal Cancer.
-
May 31, 2007
U.S. approves Wyeth kidney cancer drug
WASHINGTON (Reuters) - U.S. health regulators on Wednesday approved Wyeth's drug Torisel for patients with an advanced form of kidney cancer called renal cell carcinoma, saying it helped them live longer.
-
April 16, 2007
Brain cancer vaccine shows promise for glioblastoma
BOSTON (Reuters) - Oncophage, a vaccine that failed to prevent the recurrence of kidney cancer in a late-stage clinical trial last year, shows promise as a treatment for brain cancer, researchers said on Monday.
-
October 10, 2006
Pre-op chemotherapy benefits young cancer patients
LONDON (Reuters) - Children with advanced kidney cancer may suffer fewer long-term side effects and need less treatment if they are given chemotherapy to shrink their tumour before surgery, researchers said on Tuesday.